AI assistant
Sending…
HIKMA Pharmaceuticals PLC — Remuneration Information 2017
Apr 3, 2017
4841_rns_2017-04-03_d6c9e568-a1d1-43c8-8c54-d9d8bcf8ddff.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4241B
Hikma Pharmaceuticals Plc
03 April 2017
Block Listing Six Monthly Return
Information provided on this form must be typed or printed electronically and provided to an RIS.
Date: 3 April 2017
| Name of applicant: | Hikma Pharmaceuticals PLC | |||
| Name of scheme: | Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP") & Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") & Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP") & Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") |
|||
| Period of return | From: | 1 October 2016 | To: | 31 March 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | SOP: 792,700 ordinary shares of 10 pence LTIP: 305,031 ordinary shares of 10 pence MIP: 111,007 ordinary shares of 10 pence EIP: 0 ordinary shares of 10 pence |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | SOP: 0 ordinary shares of 10 pence LTIP: 121,000 ordinary shares of 10 pence MIP: 200,000 ordinary shares of 10 pence EIP: 379,000 ordinary shares of 10 pence |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | SOP: 0 ordinary shares of 10 pence LTIP: 35,940 ordinary shares of 10 pence MIP: 393 ordinary shares of 10 pence EIP: 14,394 ordinary shares of 10 pence |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | SOP: 792,700 ordinary shares of 10 pence LTIP: 390,091 ordinary shares of 10 pence MIP: 310,614 ordinary shares of 10 pence EIP: 364,606 ordinary shares of 10 pence |
|||
| Name of contact: | Peter Speirs |
| Telephone number of contact: | 0207 399 2772 |
| Stock Option Plan ("SOP") | ||||
| Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
| 01/10/2016 | - | - | 792,700 | Blocklisting return on 01/10/16 |
| 01/04/2017 | - | - | 792,700 | Blocklisting return on 01/04/17 |
| Long Term Incentive Plan ("LTIP") | ||||
| Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
| 01/10/2016 | - | - | 305,031 | Blocklisting return on 01/04/16 |
| 10/10/2016 | 0 | 6,463 | 298,568 | |
| 23/10/2016 | 121,000 | 0 | 419,568 | |
| 08/11/2016 | 0 | 5,565 | 414,003 | |
| 10/11/2016 | 0 | 7,964 | 411,147 | |
| 14/11/2016 | 0 | 6,463 | 399,576 | |
| 09/01/2017 | 0 | 5,000 | 394,576 | |
| 17/03/2017 | 0 | 4,485 | 390,091 | |
| 01/04/2017 | - | - | 390,091 | Blocklisting return on 01/04/17 |
| Management Incentive Plan ("MIP") | ||||
| Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
| 01/10/2016 | - | - | 111,007 | Blocklisting return on 01/10/16 |
| 23/10/2016 | 200,000 | 0 | 311,007 | |
| 16/02/2016 | 0 | 393 | 310,614 | |
| 01/04/2017 | - | - | 310,614 | Blocklisting return on 01/04/17 |
| Executive Incentive Plan ("EIP") | ||||
| Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
| 01/10/2016 | - | - | 111,007 | |
| 23/10/2016 | 379,000 | 0 | 379,000 | |
| 04/01/2017 | 0 | 7,775 | 371,225 | |
| 05/01/2017 | 0 | 3,713 | 367,512 | |
| 17/02/2017 | 0 | 2,906 | 364,606 | |
| 01/04/2017 | - | - | 364,606 | Blocklisting return 01/04/17 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRUGUWACUPMGCW
More from HIKMA Pharmaceuticals PLC
Director's Dealing
2026
Jun 2
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 1
Transaction in Own Shares
2026
Jun 1
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 18
Regulatory Filings
2026
May 15
Transaction in Own Shares
2026
May 11
Director's Dealing
2026
May 6
Transaction in Own Shares
2026
May 5